Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
Portfolio Pulse from Benzinga Insights
Over the past 5 years, Cytokinetics (NASDAQ:CYTK) has significantly outperformed the market, with an annualized return of 46.76% and an average annual return of 59.6%, growing a $1000 investment to $10,649.92. The company now has a market capitalization of $7.70 billion.
February 09, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cytokinetics has shown remarkable growth over the past 5 years, with a $1000 investment growing to $10,649.92, reflecting an annualized return of 46.76%.
The significant outperformance of Cytokinetics compared to the market, as evidenced by its 46.76% annualized return and growth of a $1000 investment to $10,649.92, indicates strong company performance and investor confidence. This historical performance, coupled with a current market capitalization of $7.70 billion, suggests a positive outlook for CYTK's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100